TriSalus Life Sciences, Inc. (TLSI)
7.305
-0.20
(-2.60%)
USD |
NASDAQ |
Dec 12, 16:00
7.295
-0.01
(-0.14%)
Pre-Market: 20:00
TriSalus Life Sciences Research and Development Expense (Quarterly): 5.176M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ICU Medical, Inc. | 21.25M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |
| VolitionRX Ltd. | 2.022M |
| Catheter Precision, Inc. | 0.276M |